Sep 24, 2024
How to Charm the FDA in Six Meeting Types or Less
Vivpro Corporation has partnered with experts and industry leaders to discuss critical pharma and biotech topics. Our goal is to share valuable information and allow the audience to engage with questions while they receive real-time feedback.
For our September session, we are joined by:
Dr. Joga Gobburu, Co-Founder, Vivpro Corp & Executive Director, Center of Translational Medicine, School of Pharmacy. University of Maryland, Baltimore
Adam George, PharmD, President and Founder of ANG Regulatory Consulting, LLC
At this WebChat you will gain insights into the following:
1. What new meetings does PDUFA VII introduce for Sponsors?
2. Is FDA's INTERACT meeting for me?
3. What topics can be discussed at a Type D meeting?
4. Type B vs Type B (EOP) meetings - are they different?
About Adam George, PharmD
Adam, Founder & President of ANG Regulatory Consulting, LLC, brings 18 yrs of regulatory affairs & clinical dev experience in oncology & benign hematology. Former FDA clinical reviewer & VP at PureTech Health, he specializes in regulatory strategy & product dev, aiding clients globally.
